Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Advanced Oncotherapy PLC Issues 100,000,000 New Shares to Private Investor


Wednesday, 24 Apr 2013 02:00am EDT 

Advanced Oncotherapy PLC announced the allotment and issue of 100,000,000 new ordinary shares (the New Ordinary Shares) of the Company at a subscription price of 1 pence per New Ordinary Share. The New Ordinary Shares were placed by Peterhouse Corporate Finance Limited and the New Ordinary Shares will be issued solely to Mr. Michael Bradfield. Based on the subscription price, the gross proceeds of the issue are £1 million. The New Ordinary Shares being issued represent an increase of approximately 27.8% of the enlarged share capital post admission. Application has been made for the New Ordinary Shares to be admitted to trading on AIM and it is expected that trading will commence on April 29, 2013. The New Ordinary Shares will rank pari passu in all aspects with the existing ordinary shares of the Company. On admission, the Company will have 359,410,368 ordinary shares in issue. 

Company Quote

3.9
0.0 +0.00%
19 Dec 2014